| Tag | Content |
|---|
EnhancerAtlas ID | HS098-11633 |
Organism | Homo sapiens |
Tissue/cell | HSMM |
Coordinate | chr11:122581640-122583620 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr5a2 | MA0505.1 | chr11:122582319-122582334 | CCTGGCCTTGGCCTC | - | 6.13 | | TFAP2C | MA0524.2 | chr11:122582301-122582313 | TGCCCCCGGGCA | - | 6.02 | | TFAP2C | MA0524.2 | chr11:122582301-122582313 | TGCCCCCGGGCA | + | 6.37 |
|
| | Number of super-enhancer constituents: 8 | ID | Coordinate | Tissue/cell |
| SE_09703 | chr11:122582306-122583673 | CD14 | | SE_25355 | chr11:122580811-122600389 | DND41 | | SE_30540 | chr11:122582636-122583651 | Fetal_Muscle | | SE_44565 | chr11:122579168-122582893 | NHDF-Ad | | SE_46121 | chr11:122575434-122583598 | Osteoblasts | | SE_53452 | chr11:122581481-122583668 | Spleen | | SE_59613 | chr11:122525607-122628654 | Ly4 | | SE_61505 | chr11:122561031-122628026 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH11I122705 | chr11 | 122576132 | 122583541 |
|
Enhancer Sequence | ATAATTTTCA AATCATCCCT TTTCATTGAC AGGCCATAGA GGAAACATTG GTCTTGACTC 60
TTGTTTCAGA AAATAAGGTC CCAGCAAAGT CAATGGGTTA GGAAGTGTGG GAGCCCTGTT 120
CTCTGATGAC TGTTGGAAAC GAGATTCATG GAAGGAAGCC TGGGCTCTCC TGACTCTGTG 180
CTTCAGTGTC CAGGCAGAAT CTCCTCAGTT AATTCTCCAG AAGAGAGCCC CCACCCTTCC 240
TCTTTATACA CTCTGGCAAG GGAGCTCCTA ATCTTGCAGT CCCAGGCTCC CAAAATCTCT 300
GTAGCAGACA TTTTTGGGGG TCCCCCATCT CCTGTCCAAA CCTTGGAATT CGTAATCATT 360
TTAGTGCTTA GGGAAAGAGA GGAGAGGTAA TCAGACCCTA TTCCAAATGC ATCTCTTTCC 420
TTCCATTTTT CTTTCGTCAC TCTCCAGCCA CGTGGGTCCC ATCACAAGTC ATCAATAACA 480
AGATGGTCAC CCCTGAGTCC AAGGGAGGCT CACAAGACTC AGGCAGAGTG AAGCTGAGCA 540
CAGGGCAGGA TGTGATAAGC AGGCCTGAAC GGAGCCGAGG AAGGCCGGGC ACTGGCAGCC 600
TTTAAGTGCC TTGCAAGGAC ATGTGCCGGG AGTGCGTGTA TGCCTCTAAG TCTCCTGAGC 660
ATGCCCCCGG GCACTTCAGC CTGGCCTTGG CCTCATTACT ACCTCATGCT GTGTAACGGG 720
CACAGGTGCA TGTGGAAAAA GAATCAAGGT TTTCTGATAG AACCAATTTC CTTTACTGGA 780
GTTTGCAAAT AACCTGCTGT CCTTGGGCCT TTGCATTTCC ATCTCTAAAA TGGGAATACT 840
AATCCTGCCT TCAATGTCCC ACTGACTACA TACACCCCTC ACAAAGATAC TGTGAGGAAG 900
AGTGAGTAAT AGCAAAGAAT CTTAAGGCTA AAAGAACCCC AGGGTTCATT TTTTTCTATC 960
CCTTTACTTC CAGCCAAGTT CTCTACACAA TAATACCCAT ACCAAAGAAA GGAATGTGCC 1020
GGGCATAAAG ACCATCTAGA AAGGACAGCC CGCAGCTTCC CCTTGGTTTG AAGCCAAGTT 1080
GGAAGTTGTC ATGCCAGCTG CATTTTTTTT TTTTTTTTTA CTGCATTGCT GTTCATCATC 1140
AAGTAATTCA GGGCACTAGG GGGAAAAAAC TTCTCTGAAA ATGAGGGAGT GATTTGCAGC 1200
ATCTGTTATT TCCTTTTTAA TTGAATCTGT TCTTCTCAGA TACCAGGAGC AAGTGCCAAA 1260
GTCAGCAGTA GAATTCAGCT GTGTACATTT TGAACGAGCT GGAAGATAAG TTTATGAGCA 1320
CTATACGGAT GCAGATTGTA CAGAAACCAG ATGGCCATAT TGTCCTCAAA GTCCTCTGGA 1380
GGGCGGTAGC TGACATGAAG CTCCAGCATG AGGAGGTGGG AGGTCTGCTG ACTTTCCTAA 1440
GGAGCTGCTT GGGTAGATAC ACACCCAGGG TGGACTTGGA TGCTTCCTTG GTGGGGGACG 1500
CACGTCACAC GAGAGGGGCT TTCTCAGCAG CCCAAATGGA CCCAGGGGCT CTCATGCTTG 1560
CTTCCATCCT GGCCCTGAGT AATAGGCATA AACCAGGGTC CTGTTGGTGC TCGCTCTTTT 1620
TCCCTCACAT TCTGCATCCT GTTGAGCACC AGGAGGGTCA CCAAGGGAAG CTAGGGAATT 1680
TCTACCCCAG AAAGTACCCA ACAGCCCTGA CTAGCTGGGA GGCAAGAGGA GAACTCCATG 1740
GGTTTCACAG GTACCTTCCT ACCTGTGGTG TTGCACAAAC AAAAGCAAAC GCCCTGAAGT 1800
ATATAGAACT CCACTACCAA GTGCAGCTTC TTAACAGCAG TTACATTTGC AGGAGAAGAG 1860
GGGATTTTGC TCCTGGATGA ATGAGGAATA GTGGTACAGG GATGTACATC TCTGAGCTGA 1920
GCCCCAGGAA GCTGACTGGA CATTCATCTT TCTTCTCTGG GTGGTTTTTT TTTTTTTTTT 1980
|
